GGrantIndex
Sort

261,768 grants matching gene therapy

NIDCD Core for Clinical Research and Care

$2,540,955
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2021 · DC

Novel Strategies to Improve Blood Transfusion Practice

$2,540,895
Hongbo R Luo · Brigham And Women'S Hospital · P01 · FY2024 · HL

UNIVERSITY OF MASSACHUSETTS CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE

$2,540,582
John L Sullivan · Univ Of Massachusetts Med Sch Worcester · UL1 · FY2011 · RR

Targeted Therapies for Glioma

$2,539,918
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2024 · CA

CONSOLIDATED BASIC CANCER RESEARCH PROGRAM

$2,539,719
Wistar Institute · P30 · FY2004 · CA

Targeted Therapies in Melanoma

$2,538,781
Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA

Pharmacogenetics Network For Cardiovascular Risk Therapy

$2,538,048
University Of Calif-Lawrenc Berkeley Lab · U01 · FY2001 · HL

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,537,842
Robert A Britton · Baylor College Of Medicine · U19 · FY2023 · AI

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,537,053
Christopher K Glass · University Of California, San Diego · P01 · FY2020 · HL

Oxidative Modification Of Proteins

$2,537,006
Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Experimental Therapy for Brain Tumors

$2,536,844
John H Sampson · Duke University · P01 · FY2020 · CA

Psychotherapy Development Research Center

$2,535,538
Kathleen M Carroll · Yale University · P50 · FY2015 · DA

MOLECULAR & CELLULAR MECHANISMS IN TRANSFUSION MEDICINE

$2,535,513
Peter J Newman · Versiti Wisconsin, Inc. · P01 · FY2010 · HL

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,535,398
Anna Wald · University Of Washington · P01 · FY2017 · AI

Control of Gene Expression and Life Span

$2,535,115
Stephen L. Helfand · Brown University · RF1 · FY2019 · AG

Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell

$2,535,000
Monica L Guzman · Weill Medical Coll Of Cornell Univ · DP2 · FY2010 · OD

MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER

$2,534,953
Sloan-Kettering Institute For Cancer Res · P50 · FY2004 · CA

SARS-CoV adaptations through a Systems Biology Lens (SYBIL)

$2,534,738
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI

Precision Delivery and Imaging to Enhance Solid Tumor Therapy

$2,534,428
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2022 · CA

SPORE IN BREAST CANCER

$2,534,107
Baylor College Of Medicine · P50 · FY2000 · CA

Tumor organoids and cell polarity: models and mechanisms for cancer research

$2,533,692
Senthil Muthuswamy · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Creating Comprehensive Maps of Worm and Fly Transcription Factor Binding Sites

$2,533,338
Robert H Waterston · University Of Washington · U41 · FY2013 · HG

The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types

$2,533,330
Ernest Fraenkel · Massachusetts Institute Of Technology · RF1 · FY2025 · AG

SPORE IN PROSTATE CANCER

$2,532,522
William George Nelson · Johns Hopkins University · P50 · FY2007 · CA

Chromatin Structure and Gene Expression

$2,532,437
Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA